“…The use of biological approaches to generate bispecic antibodies was started two decades ago [20][21][22] such as the knobs-intoholes strategy, 23 strand-exchange engineered domain (SEED) CH 3 heterodimers approach, 24 orthogonal Fab interface, 25 and CorssMab design. 26 Recently, chemical approaches [27][28][29][30][31][32][33][34][35] to develop bispecic antibodies has recently emerged, which shows advantages in the bispecic antibody production.…”